New Research Affirms U=U | |
 | The PARTNER2 study provides the most definitive data yet that the concept of U=U (undetectable equals untransmittable) is objective truth -- for MSM and heterosexuals alike. |
Getting Real About Long-Acting ART | |
 | Anton Pozniak, M.D., explores a critical question around long-acting antiretrovirals: Once viable options have reached the market, what will be their true impact? |
PrEP: Every Day, or on Demand? | |
 | Interim results from the Prévenir study suggest that, for men who have sex with men, either dosing approach can be successful. |
Dolutegravir and Pregnancy: What's the Risk? | |
 | Lynn Mofenson, M.D., of the Elizabeth Glaser Pediatric AIDS Foundation discusses recent findings on babies born with neural tube defects to women living with HIV. |
An ongoing series to help providers set the foundations of a patient's care.
What's New or Notable in HIV Treatment and Prevention Adherence?
Progress and Gaps in Scaling Up Universal HIV Treatment in Africa
Starting HIV Treatment Soon After Diagnosis Trims Time to Viral Suppression
What's the Next Game-Changer in HIV Treatment?
The field of hepatitis C disease management is in the midst of dramatic change. This series provides overviews, research updates, and more.
Hepatitis C: How Is It Transmitted and Who Should Be Tested?
Addressing Hepatitis C Treatment Barriers Among HCV/HIV-Coinfected Patients
What Are the Hepatitis C Genotypes?
Hepatitis C Resources, Services and Information
Primary Care Doctors "Not Doing Enough" to Curb STDs
How Innovation Can Help End the AIDS Epidemic by 2030
Prison Health Is Public Health: The Case for Testing and Treating Hepatitis C in Prisons
This Week in HIV Research: Gender Disparities Among the Formerly Incarcerated
PositiveLinks: Mobile Intervention for People With HIV
What Is the State of the Art in HIV Treatment and Prevention?
Combining Broadly Neutralizing Antibodies Shows Promise
Lessons for Infectious Disease Doctors: Treating HIV, Pain, and Mental Illness
Effects of Trauma on Reproductive Decisions by People Living With HIV
This Week in HIV Research: A New Frontier in Organ Transplantation
New York City's Hotline for HIV Exposure a Success, Study Finds
New Study From Georgia Sheds Light on Kaposi Sarcoma in Women With HIV
British Columbia Study Underscores Need for Mental Health Services for HIV-Positive People
Fixed-Dose Doravirine Combination Non-Inferior in Treatment-Experienced Patients
Jamaican Study of Serodiscordant Couples Highlights Challenges of PrEP Awareness
Sex and the HIV Reservoir: New Research Points to the Powerful Effect of Estrogen
First U.S. Failure of Truvada as PrEP Is Reported at IDWeek
Post-AIDS 2018 Updates on HIV Cure Research
On-Demand PrEP Is Great. Now, What About Women?
High Rates of Anal HPV Infection in Gay Men Using PrEP in IPERGAY: The Role of Vaccination
Ariel Sabillon Is a Gay Latinx Immigrant and More Than His HIV Criminalization Case
What's Hot in HIV Clinical Science
This Week in HIV Research: Food, It Does a Body Good
The Reunion Project Seeks to Build an HIV Research Agenda for Long-Term Survivors
© 2018 Remedy Health Media, LLC. All Rights Reserved
TheBodyPRO: About TheBodyPRO | Contact TheBodyPRO | Content Policy | Advertise With Us
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
TheBodyPRO is a service of Remedy Health Media, 461 Fifth Avenue, 14th Floor, New York, NY 10017. TheBodyPRO and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBodyPRO's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBodyPRO is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBodyPRO should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
